logo
episode-header-image
Feb 2015
4m 9s

Personalised Medicine

OXFORD UNIVERSITY
About this episode
Dr Jenny Taylor is the Programme Director for the Genomic Medicine Theme, Wellcome Trust Centre for Human Genetics. Her research bridges the gap between genetics research and the use of its discoveries in diagnosis or treatment of medical conditions. Clinical diagnoses can be broad descriptions, but today's test results can help better understand the conditi ... Show More
Up next
Oct 2015
Melanoma
Melanoma or skin cancer is one of the fastest rising cancer types. When identified early, melanoma is relatively easy to cure, but once it starts to metastasise, it becomes very difficult to treat. DEREGULATION OF TRANSCRIPTION The interface between signal transduction and transc ... Show More
7m 2s
Oct 2015
Targeting epigenetics to treat cancer
Transcription is a tightly regulated process, where chemical modifications initiate the duplication of genetic material. This epigenetic process is often dysregulated in cancer, but it can be targeted with small molecule inhibitors. EPIGENETIC SIGNALLING Professor Panagis Filippa ... Show More
4m 37s
Mar 2015
Human Cancer Genetics
Dr Gareth Bond, Associate Member of the Ludwig Institute for Cancer Research, studies the influence of genetic variants on the origins, progression and treatment of human cancer. SNP - single nucleotide polymorphisms There is great heterogeneity between individuals in their risk ... Show More
5m 12s
Recommended Episodes
Jul 2013
Human Genetics
Professor Peter Donnelly tells us how genetics helps us to understand common diseases and develop new drugs. Understanding which variations in our DNA affect susceptibility to diseases can provide new insights into the disease process and lead to new treatments. Professor Peter D ... Show More
5m 49s
Mar 2024
Mestastasen ohne Ursprung: CUP-Syndrom zielgerichtet behandeln?
Mit Prof. Dr. Alwin Krämer, Krebsforscher und Onkologe Das CUP-Syndrom (Cancer of Unknown Primary) macht etwa 2–4 % aller neu diagnostizierten Krebserkrankungen aus. Trotz modernster Diagnostik werden bei den Betroffenen zwar Metastasen entdeckt, aber kein dazugehöriger Ursprungs ... Show More
33m 25s
Feb 2022
Special Episode: Ki67 as a Prognostic and Predictive Biomarker in HR-Positive/HER2-Negative Early Breast Cancer
This 45-minute podcast features the expertise of a pathologist and an oncologist highlighting important and practice-changing developments related to the use of Ki67 biomarker testing in patients with HR-positive/HER2-negative early breast cancer, such as new clinical data with i ... Show More
44m 46s
Mar 2023
Curing cancer, from bench to bedside
Medical research sits at the intersection of the lab and the clinic. It's critical for translating breakthrough science into possible treatments for people. It's most successful when scientists and clinicians collaborate. Today, we're talking with Professor Anthony Joshua, one of ... Show More
22m 5s
Oct 2023
Early-Stage Prostate Cancer: Know Your Treatment Options
Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. In this episode, Dr. Diane Reidy-Lagunes is joined by medical oncologist Dr. Dana Rathkopf, radiation oncologist Dr. Sean McBride, and urolo ... Show More
25m 8s
Mar 2015
Emerging Infectious Diseases
Professor Peter Horby is Senior Clinical Research Fellow. His research focusses on epidemic diseases such as Ebola and bird flu, and crosses the disciplines of basic science, medical science and public health. Influenza, SARS & Ebola Research on emerging infectious diseases can o ... Show More
6m 12s